CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Comparitive study on effect of combination of metformin-vildagliptin vs metformin-glimepride on lipid profile in patients of type 2 diabetes mellitus

Author: 
Dr. Sumit Jain and Dr. Nitin Pise
Subject Area: 
Life Sciences
Abstract: 

Background: The global burden of Type 2 diabetes mellitus (T2DM) is on a rise.It is an endrocrine disorder characterised by hyperglycaemia. Cardiac morbidity in patients of long standing type 2 diabetes mellitus is said to occur due to dyslipidaemia seconadary to hyperglycaemia. Good glycaemic control may prevent such a mobidity to occur by intake of efficacious antidiabetic drugs either alone or in combination. Thus, our aim was to analyse the effect of metformin-vildagliptin vs metformin-glimepride on lipid profile of patients of type 2 diabetes mellitus. Methods: Our study was an observational comparative study where 200 patients of type 2 diabetes mellitus attending medicine department OPD at Shri Shankaracharya Institute of Medical Sciences (SSIMS), Bhillai were included. They were divided in two equal groups of 100 each, where group A were using Metformin-vildagliptin combination, whereas Group B were using Metformin- glimepride combination. All blood investigations were done to decipher glycaemic control and lipid profile status. The results of the two groups were compared and statiscally analysed. Results: Better glycaemic control was seen in patients of group A as compared to those in Group B after treatment, which was statistically significant. A reduction in triglyceride (TGL), low density lipoprotein (LDL) levels and improvement in high density lipoprotein (HDL) levels was seen in patients of Group Aas compared to those in Group B, which was statistically significant. Conclusions: Patients on combination of met formin-vildagliptin (Group A) had greater reduction in lipid profile parameters as compared to metformin- glimepride (Group B).

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran